The role of histone H3 phosphorylation (Ser10 and Ser28) in cell growth and cell transformation
✍ Scribed by Zigang Dong; Ann M. Bode
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 143 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0899-1987
- DOI
- 10.1002/mc.20220
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Histones are now regarded as integral and dynamic components of the machinery responsible for regulating gene transcription. Many types of cancer and other diseases are associated with translocations or mutations in chromatin‐modifying enzymes and regulatory proteins. Much of the work in our laboratory has focused on identifying novel histone H3 kinases and the role of histone H3 phosphorylation in cell proliferation and transformation. We are beginning to unravel the complexities of gene expression mediated by histone H3 phosphorylation, which is induced by a whole host of diverse stimuli. Dissimilar cells respond differentially to distinct stimuli, and induction of gene expression is dependent on the type of stimuli, duration and strength of stimuli, state of the cell and of course, specific cell type. Thus, regulation of histone modifications and resultant gene expression is not just one‐ or two‐dimensional but multidimensional, encompassing a huge array of factors. Significant findings such as the observation that histone H3 phosphorylation (Ser10) is critical for neoplastic cell transformation suggests that histone H3 may be a crucial target for cancer chemotherapy or genetic therapy in the future. © 2006 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract ## Background: DNA replication stress often induces DNA damage. The antitumor drug hydroxyurea (HU), a potent inhibitor of ribonucleotide reductase that halts DNA replication through its effects on cellular deoxynucleotide pools, was shown to damage DNA inducing double‐strand breaks (D
## Abstract Activating mutations in K‐Ras occur in most pancreatic cancers. We investigated whether genetic changes (K‐Ras mutations) in human pancreatic cancer cell lines altered genomic instability and epigenetic events responding to Ras‐mitogen activated protein kinase (MAPK) signaling by charac
We have recently demonstrated that transforming growth factor (TGF)-Pl and TGF-02 are potent inhibitors of the growth and differentiation of murine and human hematopoietic cells. The proliferation of primary unfractionated murine bone marrow by interleukin-3 (IL-3) and human bone marrow by IL-3 or g